364 related articles for article (PubMed ID: 29373210)
21. Very early indicators of response to systemic therapy in lymphoma patients based on alterations in water diffusivity--a preliminary experience in 20 patients undergoing whole-body diffusion-weighted imaging.
Horger M; Claussen C; Kramer U; Fenchel M; Lichy M; Kaufmann S
Eur J Radiol; 2014 Sep; 83(9):1655-64. PubMed ID: 24972451
[TBL] [Abstract][Full Text] [Related]
22. Quantification of tumor burden in multiple myeloma by atlas-based semi-automatic segmentation of WB-DWI.
Almeida SD; Santinha J; Oliveira FPM; Ip J; Lisitskaya M; Lourenço J; Uysal A; Matos C; João C; Papanikolaou N
Cancer Imaging; 2020 Jan; 20(1):6. PubMed ID: 31931880
[TBL] [Abstract][Full Text] [Related]
23. Repeatability and test-retest reproducibility of mean apparent diffusion coefficient measurements of focal and diffuse disease in relapsed multiple myeloma at 3T whole body diffusion-weighted MRI (WB-DW-MRI).
ElGendy K; Barwick TD; Auner HW; Chaidos A; Wallitt K; Sergot A; Rockall A
Br J Radiol; 2022 Sep; 95(1138):20220418. PubMed ID: 35867890
[TBL] [Abstract][Full Text] [Related]
24. Deep Learning for Automatic Bone Marrow Apparent Diffusion Coefficient Measurements From Whole-Body Magnetic Resonance Imaging in Patients With Multiple Myeloma: A Retrospective Multicenter Study.
Wennmann M; Neher P; Stanczyk N; Kahl KC; Kächele J; Weru V; Hielscher T; Grözinger M; Chmelik J; Zhang KS; Bauer F; Nonnenmacher T; Debic M; Sauer S; Rotkopf LT; Jauch A; Schlamp K; Mai EK; Weinhold N; Afat S; Horger M; Goldschmidt H; Schlemmer HP; Weber TF; Delorme S; Kurz FT; Maier-Hein K
Invest Radiol; 2023 Apr; 58(4):273-282. PubMed ID: 36256790
[TBL] [Abstract][Full Text] [Related]
25. Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma.
Giles SL; Messiou C; Collins DJ; Morgan VA; Simpkin CJ; West S; Davies FE; Morgan GJ; deSouza NM
Radiology; 2014 Jun; 271(3):785-94. PubMed ID: 24475858
[TBL] [Abstract][Full Text] [Related]
26. Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma--a whole-body MRI and diffusion-weighted imaging study.
Wu X; Nerisho S; Dastidar P; Ryymin P; Järvenpää R; Pertovaara H; Eskola H; Kellokumpu-Lehtinen PL
NMR Biomed; 2013 Sep; 26(9):1186-94. PubMed ID: 23483722
[TBL] [Abstract][Full Text] [Related]
27. Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden.
Giles SL; deSouza NM; Collins DJ; Morgan VA; West S; Davies FE; Morgan GJ; Messiou C
Clin Radiol; 2015 Jun; 70(6):614-21. PubMed ID: 25799364
[TBL] [Abstract][Full Text] [Related]
28. Apparent diffusion coefficient of vertebral haemangiomas allows differentiation from malignant focal deposits in whole-body diffusion-weighted MRI.
Winfield JM; Poillucci G; Blackledge MD; Collins DJ; Shah V; Tunariu N; Kaiser MF; Messiou C
Eur Radiol; 2018 Apr; 28(4):1687-1691. PubMed ID: 29134357
[TBL] [Abstract][Full Text] [Related]
29. Whole body MRI with DWI in people with NF1 and Schwannomatosis: Are qualitative and quantitative imaging features of peripheral lesions comparable to localized MRI?
Debs P; Fayad LM; Romo CG; Ahlawat S
Eur J Radiol; 2023 May; 162():110802. PubMed ID: 37001256
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body.
Seber T; Caglar E; Uylar T; Karaman N; Aktas E; Aribas BK
Clin Imaging; 2015; 39(5):856-62. PubMed ID: 26091745
[TBL] [Abstract][Full Text] [Related]
31. Application value of diffusion weighted whole body imaging with background body signal suppression in monitoring the response to treatment of bone marrow involvement in lymphoma.
Sun M; Cheng J; Zhang Y; Wang F; Meng Y; Fu X
J Magn Reson Imaging; 2016 Dec; 44(6):1522-1529. PubMed ID: 27160047
[TBL] [Abstract][Full Text] [Related]
32. Intravoxel Incoherent Motion Diffusion-weighted Imaging of Multiple Myeloma Lesions: Correlation with Whole-Body Dynamic Contrast Agent-enhanced MR Imaging.
Bourillon C; Rahmouni A; Lin C; Belhadj K; Beaussart P; Vignaud A; Zerbib P; Pigneur F; Cuenod CA; Bessalem H; Cavet M; Boutekadjirt A; Haioun C; Luciani A
Radiology; 2015 Dec; 277(3):773-83. PubMed ID: 26131910
[TBL] [Abstract][Full Text] [Related]
33. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous multislice diffusion-weighted imaging in whole-body positron emission tomography/magnetic resonance imaging for multiparametric examination in oncological patients.
Taron J; Schraml C; Pfannenberg C; Reimold M; Schwenzer N; Nikolaou K; Martirosian P; Seith F
Eur Radiol; 2018 Aug; 28(8):3372-3383. PubMed ID: 29484459
[TBL] [Abstract][Full Text] [Related]
35. Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study.
Yamada A; Araki Y; Tanaka Y; Otsuki S; Yamada A; Moriyama M; Katagiri S; Suguro T; Asano M; Yoshizawa S; Akahane D; Furuya N; Fujimoto H; Okabe S; Gotoh M; Suzuki K; Saito K; Gotoh A
PLoS One; 2021; 16(7):e0253025. PubMed ID: 34242226
[TBL] [Abstract][Full Text] [Related]
36. Whole-Body MRI with an Ultrahigh b-Value of 2000 s/mm
Heidemeier A; Thurner A; Metz C; Pabst T; Heidemeier H; Rasche L; Kortüm KM; Einsele H; Grimm R; Weiland E; Bley TA
Acad Radiol; 2022 Jan; 29(1):e1-e8. PubMed ID: 33139155
[TBL] [Abstract][Full Text] [Related]
37. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
38. Whole-body diffusion magnetic resonance imaging with simultaneous multi-slice excitation in children and adolescents.
Krueger PC; Krämer M; Benkert T; Ertel S; Teichgräber U; Waginger M; Mentzel HJ; Glutig K
Pediatr Radiol; 2023 Jun; 53(7):1485-1496. PubMed ID: 36920515
[TBL] [Abstract][Full Text] [Related]
39. More accurate prediction of treatment response than mean apparent diffusion coefficient value in multiple myeloma using whole body MRI histogram analysis.
Qi Q; Dong H; Ji X; Zhang K; Zou D; Hao M; Deng S; Sui W; Song Z; Yu Z; Shen Z; Huang W; Xia S
Future Oncol; 2023 Jun; 19(17):1175-1185. PubMed ID: 37386939
[No Abstract] [Full Text] [Related]
40. Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI.
Padhani AR; van Ree K; Collins DJ; D'Sa S; Makris A
AJR Am J Roentgenol; 2013 Jan; 200(1):163-70. PubMed ID: 23255758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
